PERSPECTIVE THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $29.19 thousand as of 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2014-05-15
- 2014-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $29.19K.
- 2013-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $42.63K.
- 2013-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $56.06K.
- 2013-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $82.40K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2014-03-31 | $29.19K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $42.63K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $56.06K 10-Q · filed 2013-11-14 |
| 2013-03-31 | $82.40K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $109.56K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $138.39K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $179.51K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |